Accurate Assessment of Adherence
The DOI matches its Crossref record, with a small difference in title or year; 27 of the 27 references it cites were found in a registry or an index.
Abstract
Background People with cystic fibrosis have a high treatment burden. While uncertainty remains about individual patient level of adherence to medication, treatment regimens are difficult to tailor, and interventions are difficult to evaluate. Self- and clinician-reported measures are routinely used despite criticism that they overestimate adherence. This study assessed agreement between rates of adherence to prescribed nebulizer treatments when measured by self-report, clinician report, and electronic monitoring suitable for long-term use. Methods Seventy-eight adults with cystic fibrosis were questioned about their adherence to prescribed nebulizer treatments over the previous 3 months. Self-report was compared with clinician report and stored adherence data downloaded from the I-Neb nebulizer system. Adherence measures were expressed as a percentage of the prescribed regimen, bias was estimated by the paired difference in mean (95% CI) patient and clinician reported and actual adherence. Agreement between adherence measures was calculated using intraclass correlation coefficients (95% CI), and disagreements for individuals were displayed using Bland-Altman plots. Results Patient-identified prescriptions matched the medical record prescription. Median self-reported adherence was 80% (interquartile range, 60%-95%), whereas median adherence measured by nebulizer download was 36% (interquartile range, 5%-84.5%). Nine participants overmedicated and underreported adherence. Media…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Some trials also highlighted a possible ceiling effect (Quinn 2004; Wildman 2022), as their recruited participants had baseline adherence rates already higher than 'real world' adherence (Daniels 2011;Hoo 2019;Hoo 2020;Hoo 2021).”
From Psychological interventions for improving adherence to inhaled therapies in people with cystic fibrosis (2023) · cites this paper as Daniels 2011
In the citing paper
“This is promising as it shows that the methodology is advancing alongside evidence that highlights the discrepancy between objective and subjective measures of adherence (Daniels 2011; Thorton”
From Psychological interventions for improving adherence to inhaled therapies in people with cystic fibrosis (2023) · cites this paper as Daniels 2011
In the citing paper
“The discrepancy between objective and subjective measurement has also been highlighted (Daniels 2011;Modi 2006b;Thorton 2013;Warnock 2020).”
From Psychological interventions for improving adherence to inhaled therapies in people with cystic fibrosis (2023) · cites this paper as Daniels 2011
In the citing paper
“Trials using objective recorded measures suggest that adherence to inhaled therapies in people with CF is around 31% to 36% in adults (Daniels 2011;Hoo 2019;Hoo 2020;Hoo 2021)”
From Psychological interventions for improving adherence to inhaled therapies in people with cystic fibrosis (2023) · cites this paper as Daniels 2011
In the citing paper
“Despite previous research highlighting the discrepancy between objective and subjective methods of measuring adherence to inhaled therapies in people with CF (Daniels 2011; Thorton 2013; Warnock 2020), objective measures are rarely used in practice (Robinson 2020).”
From Psychological interventions for improving adherence to inhaled therapies in people with cystic fibrosis (2023) · cites this paper as Daniels 2011
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
1 retracted
Inhaled bronchodilators for cystic fibrosis
Halfhide, C. P., Evans, H. J., & Couriel, J. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003428.pub2 · Cited by 66
RetractedSTATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT
Martin Bland, J., & Altman, D. (1986) · The Lancet · doi:10.1016/s0140-6736(86)90837-8 · Cited by 47,965
(1965) · The Lancet · doi:10.1016/s0140-6736(65)91037-8 · Cited by 16,856
A systematic review of adherence with medications for diabetes
Cramer, J. A. (2004) · Diabetes Care · doi:10.2337/diacare.27.5.1218 · Cited by 1,203
The diagnosis of cystic fibrosis: A consensus statement
Rosenstein, B. J., & Cutting, G. R. (1998) · The Journal of Pediatrics · doi:10.1016/s0022-3476(98)70344-0 · Cited by 1,086
High treatment burden in adults with cystic fibrosis: challenges to disease self-management
Sawicki, G. S., Sellers, D. E., & Robinson, W. M. (2009) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2008.09.007 · Cited by 498
Evidence-based Assessment of Adherence to Medical Treatments in Pediatric Psychology
Quittner, A. L., Modi, A. C., Lemanek, K. L., Ievers-Landis, C. E., & Rapoff, M. A. (2008) · Journal of Pediatric Psychology · doi:10.1093/jpepsy/jsm064 · Cited by 329
Barriers to Treatment Adherence for Children with Cystic Fibrosis and Asthma: What Gets in the Way?
Modi, A. C., & Quittner, A. L. (2006) · Journal of Pediatric Psychology · doi:10.1093/jpepsy/jsj096 · Cited by 301
A multi-method assessment of treatment adherence for children with cystic fibrosis
Modi, A. C., Lim, C. S., Yu, N., Geller, D., Wagner, M. H., & Quittner, A. L. (2006) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2006.03.002 · Cited by 265
Treatment compliance in adults with cystic fibrosis.
Abbott, J., Dodd, M., Bilton, D., & Webb, A. K. (1994) · Thorax · doi:10.1136/thx.49.2.115 · Cited by 188
Compliance with treatment in adult patients with cystic fibrosis.
Conway, S. P., Pond, M. N., Hamnett, T., & Watson, A. (1996) · Thorax · doi:10.1136/thx.51.1.29 · Cited by 182
Self-citationElectronic Monitoring of Medication Adherence: When Is High-Tech Best?
Riekert, K. A., & Rand, C. S. (2002) · Journal of Clinical Psychology in Medical Settings · doi:10.1023/a:1014131928789 · Cited by 159
Determinants of adherence in adults with cystic fibrosis
Kettler, L. J. (2002) · Thorax · doi:10.1136/thorax.57.5.459 · Cited by 147
Patient-Reported Compliance with Cystic Fibrosis Therapy
Passero, M. A., Remor, B., & Salomon, J. (1981) · Clinical Pediatrics · doi:10.1177/000992288102000406 · Cited by 120
Patient adherence with COPD therapy
Rand, C. S. (2005) · European Respiratory Review · doi:10.1183/09059180.05.00009604 · Cited by 91
The Adaptive Aerosol Delivery (AAD) Technology: Past, Present, and Future
Denyer, J., & Dyche, T. (2010) · Journal of Aerosol Medicine and Pulmonary Drug Delivery · doi:10.1089/jamp.2009.0791 · Cited by 82
Typologies of Nonadherence in Cystic Fibrosis
KOOCHER, G. P., McGRATH, M. L., & GUDAS, L. J. (1990) · Journal of Developmental & Behavioral Pediatrics · doi:10.1097/00004703-199012000-00015 · Cited by 75
Electronic monitoring: Adherence assessment or intervention?
Wagner, G., & Ghosh-Dastidar, B. (2002) · HIV Clinical Trials · doi:10.1310/xgxu-fudk-a9qt-mptf · Cited by 75
McNamara, P. S., McCormack, P., McDonald, A. J., Heaf, L., & Southern, K. W. (2009) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2009.04.006 · Cited by 72
True device compliance: the need to consider both competence and contrivance
Brennan, V. K., Osman, L. M., Graham, H., Critchlow, A., & Everard, M. L. (2004) · Respiratory Medicine · doi:10.1016/j.rmed.2004.05.015 · Cited by 62
Understanding non-compliance with treatment in adults with cystic fibrosis.
Dodd, M. E., & Webb, A. K. (2000) · PubMed Central · Cited by 60
Psychological interventions for people with cystic fibrosis and their families
Glasscoe, C. A., & Quittner, A. L. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003148.pub2 · Cited by 49
Adherence to nebulised antibiotics in cystic fibrosis
Latchford, G. J., Duff, A. J. A., Quinn, J., Conway, S., & Conner, M. T. (2008) · Patient Education and Counseling · doi:10.1016/j.pec.2008.08.027 · Cited by 49
Self-citationNon-adherence to treatment in cystic fibrosis.
Lask, B. D. (1994) · PubMed · Cited by 47
Nebulised dornase alpha: adherence in adults with cystic fibrosis
Burrows, J. A., Bunting, J., Masel, P. J., & Bell, S. C. (2002) · Journal of Cystic Fibrosis · doi:10.1016/s1569-1993(02)00095-4 · Cited by 46
Regimen and Device Compliance: Key Factors in Determining Therapeutic Outcomes
Everard, M. L. (2006) · Journal of Aerosol Medicine · doi:10.1089/jam.2006.19.67 · Cited by 19
Archer, M., Williams, V., & Rayner, R. J. (2010) · Journal of Cystic Fibrosis · doi:10.1016/s1569-1993(10)60045-8 · Cited by 1
Research works printed but not linked: 3
- Dodd, 1998, The medical and economic consequences of non-compliance in clinical trials and in primary care [Abstract], Thorax, 53, A18
- Nikander, 2008, Use of I-Neb Insight to examine patient logging system data from a 3-month evaluation of the I-Neb AAD system, Respir Drug Del, 3, 735
- Prince, 2006, I-Neb Insight: a new tool for monitoring inhaled medication use, Eur Respir J, 28, 261s
Cited by
Update on Key Emerging Challenges in Cystic Fibrosis
Jennings, M. T., Riekert, K. A., & Boyle, M. P. (2014) · Medical Principles and Practice · doi:10.1159/000357646 · Cited by 3,648
The future of cystic fibrosis care: a global perspective
Bell, S. C., Mall, M. A., Gutierrez, H., Macek, M., Madge, S., Davies, J. C., Burgel, P.-R., Tullis, E., Castaños, C., Castellani, C., et al. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(19)30337-6 · Cited by 974
Blaschke, T. F., Osterberg, L., Vrijens, B., & Urquhart, J. (2012) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-011711-113247 · Cited by 419
Nguyen, T.-M.-U., Caze, A. L., & Cottrell, N. (2014) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12194 · Cited by 417
Drug Delivery to the lungs: Challenges and Opportunities
Newman, S. P. (2017) · Therapeutic Delivery · doi:10.4155/tde-2017-0037 · Cited by 328
Metadata
- Authors
- Daniels, T., Goodacre, L., Sutton, C., Pollard, K., Conway, S., & Peckham, D.
- Affiliations
- York Hospital (GB)
- University of Lancashire (GB)
- Leeds Teaching Hospitals NHS Trust (GB)
- Corresponding author
- Daniels, Tracey
- Venue
- Chest
- Publisher
- Elsevier BV
- Published
- 2011-08
- Volume
- 140
- Issue
- 2
- Pages
- 425-432
- ISSN
- 0012-3692 (ISSN-L)
- OpenAlex
- W2086921502
- Cited by
- 210
- References
- 27
- Citations by year
- 2026: 4 · 2025: 5 · 2024: 11 · 2023: 12 · 2022: 32 · 2021: 13 · 2020: 18 · 2019: 15 · 2018: 11 · 2017: 16 · 2016: 14 · 2015: 15 · 2014: 17 · 2013: 14 · 2012: 7
- FWCI
- 12.65
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- Locations
- CHEST Journal (publishedVersion)
- PubMed (publishedVersion)
- CLOK (University of Central Lancashire) (submittedVersion)
- Research Explorer (The University of Manchester) (submittedVersion)
- Topics
- Health Sciences › Medicine › Family Practice › Medication Adherence and Compliance
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Cystic Fibrosis Research Advances
- Health Sciences › Health Professions › Pharmacy › Pharmacy and Medical Practices
- Keywords
- cystic fibrosis, medication adherence, electronic monitoring, self-report, treatment burden
- MeSH terms
- Adult, Cystic Fibrosis, Electronics, Female, Humans, Male, Nebulizers and Vaporizers, Medication Adherence, Young Adult, Self Report
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.